Companies

ANAPTYSBIO, INC (ANAB) SEC filings

CIK 0001370053 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · incorporated in DE · fiscal year ends 06/30

Annual financials (from the company's own XBRL in its 10-K filings)

FY2025FY2024FY2023FY2022
Revenue (USD)17.2 M10.3 M63.2 M75.0 M
Net income (USD)-128.7 M-57.8 M-19.9 M
Diluted EPS (USD/shares)-6.08-4.57-2.11-0.73

Latest filings

FiledFormDescriptionPeriod
2026-10-02442026-10-01
2026-10-01144144
2026-09-2110-KT10-KT2026-06-30
2026-09-218-K8-K items 9.012026-09-21
2026-09-17442026-09-15
2026-08-14SCHEDULE 13G/ASCHEDULE 13G/A
2026-08-118-K8-K items 5.07,9.012026-08-11
2026-08-07442026-03-12
2026-08-07442026-03-12
2026-07-308-K8-K items 7.012026-07-28
2026-07-13144144
2026-06-30144144
2026-06-29144144
2026-06-29ARSARS2025-12-31
2026-06-29DEFA14ADEFA14A
2026-06-29DEF 14ADEF 14A2026-06-29
2026-06-26144144
2026-06-228-K8-K items 1.012026-06-15
2026-06-17144144
2026-06-17442026-06-15
2026-06-17442026-06-15
2026-06-17442026-06-15
2026-06-16144144
2026-06-15144144
2026-06-12144144

Forms on file (last 1,000): 4 266, 8-K 115, 144 68, SC 13G/A 43, 3 30, 10-Q 28, SC 13G 23, SCHEDULE 13G/A 17. Source: SEC EDGAR, as filed; this page is public data and not investment advice.

For software and AI agents: the same data as JSON, per call, no account: GET https://store.agentexchange.work/gw/filings/company?ticker=ANAB (0.002 USD), /gw/filings/filings?ticker=ANAB&form=8-K, /gw/filings/facts?ticker=ANAB&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txt

Updated from EDGAR within 30 minutes of a filing. Agent Exchange